Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
FDA
Jul 24, 2024, 01:01 |
Blog
Petros Grivas: Uromigos cup came to Greek home
Petros Grivas shared a post on X: ''Uromigos cup came to Greek home! Fantastic memories from…
Jul 23, 2024, 22:30 |
Blog
Hagop Kantarjian: The simultaneous combination of ponatinib and blinatumomab highly effective
Hagop Kantarjian shared on X: "The simultaneous combination of ponatinib and blinatumomab highly effective: MRD-negativity rate…
Jul 23, 2024, 15:52 |
Drugs
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
In the rapidly evolving field of oncology, we are witnessing remarkable advancements in various treatment…
Jul 22, 2024, 16:46 |
Insight
Friends HRD Harmonization Project with Patsy Hinson - Friends of Cancer Research
Friends of Cancer Research shared on X: "It is very important for patients to have…
Jul 21, 2024, 13:57 |
Blog
Herbert Loong: Regulatory processes for novel oncology therapeutics and cellular therapies at APODDC forum
Herbert Loong shared a post on X: ''We welcomed Ke Liu, former Chief of Oncology…
Jul 21, 2024, 10:58 |
Blog
Chadi Hage Chehade: NGS testing rates in patients with metastatic prostate and urothelial cancers
Petros Grivas shared a post by Chadi Hage Chehade, Post-Doctoral Research Fellow at Huntsman Cancer Institute, on X:…
Jul 20, 2024, 21:26 |
Blog
David Fajgenbaum: Santa Claus theory of civilization
David Fajgenbaum, Associate Professor of Medicine at University of Pennsylvania School of Medicine, shared on…
Jul 20, 2024, 18:07 |
Blog
Tom Powles: More evidence that PD(L)1 re-challenge should be avoided in renal cancer
Tom Powles posted on X/Twitter: "More evidence that PD(L)1 re-challenge should be avoided in renal…
Jul 19, 2024, 22:55 |
Blog
What after Osimertinib failure?
Abhishek Pathak, Professor at the Indian Army, shared a post on X: "What after Osimertinib…
Jul 19, 2024, 22:19 |
Insight
Yüksel Ürün: Congratulations all new participants of the ASCO Leadership Development Program!
Yüksel Ürün shared a post by Miriam Knoll, on X, adding: "Congratulations to you and…
43
44
45
46
47
All:
946
Posts:
441 - 450
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube